abstract: Progesterone, estrogen and cyclic adenosine monophosphate (cAMP) together regulate the decidualization of human endometrial stromal cells in a time-dependent manner. The role of DNA methylation and the three active DNA methyltransferases (DNMTs) in the regulation of decidualization is gaining interest but the exact role of this epigenetic mechanism during decidualization is largely unknown. We aimed to understand the effect of the main regulators of decidualization on the expression of the DNMTs and in turn on the expression of steroid hormone receptors during the decidualization. We conducted a time-course analysis from 6 h to 10 days to examine the change in gene expression of the DNMTs and the steroid hormone receptors over time in response to estradiol, medroxy-progesterone acetate (MPA) and dibutyryl-cAMP (db-cAMP) in a human endometrial stromal cells (HESC) cell line. Only the combination treatment with MPA-mix (estradiol + MPA + db-cAMP) up-regulated ERa, PGR, progesterone receptor B (PRB) and androgen receptor at 24 h. Both decidualization pathways of db-cAMP and estradiol/MPA, independently and combined, consistently down-regulated DNMT3B mRNA expression from 6 h till 10 days, whereas DNMT1 and DNMT3A mRNA expression were down-regulated transiently. Forced expression of DNMT3B in HESC for 10 days attenuated IGFBP1 mRNA and protein expression; and forced expression of DNMT3B combined with MPA-mix treatment synergistically increased the expression of PRB at 24 h. The HESC morphology and proliferation remained unchanged in response to forced expression of DNMT3B. In conclusion, mRNA expression of the DNMTs during decidualization is dynamic, so that expression varies according to the cAMP or estradiol/MPA pathway treatments that regulate them in a time-dependent manner. Although forced expression of DNMT3B by itself is insufficient to inhibit decidualization, forced expression of DNMT3B in combination with MPA-mix synergistically upregulated PRB, as well as attenuated the expression of IGFBP1, the decidualization marker.
Introduction
Progesterone, estrogen and cyclic adenosine monophosphate (cAMP), the second messenger, together induce and regulate the decidualization of human endometrial stromal cells in a time-dependent manner. The differentiation of stromal cells into decidual cells during the secretory phase of the menstrual cycle takes at least 10 days in vivo (de Ziegler et al., 1998) . During this time, the 'window of implantation' of endometrial receptivity to blastocyst implantation is open for 4 days (Psychoyos, 1986; Bergh and Navot, 1992) . In the absence of pregnancy, the consequent decline in progesterone levels causes the endometrium to break down and shed during menstruation. The ovarian hormones progesterone and estrogen are essential for decidualization and mainly act through their respective receptors, i.e. progesterone receptors (PRs) PRA and PRB and estrogen receptors (ERs) ERa and ERb; and the androgen receptor (AR) is also involved in decidualization (Cloke et al., 2008) . The molecular mechanisms that regulate decidualization are still not completely understood. The role of epigenetic mechanisms in the regulation of decidualization, particularly DNA methylation and histone modification, is receiving increased interest (Guo, 2011) . The histone modifications of acetylation and methylation have been shown to regulate decidualization (Sakai et al., 2003; Munro et al., 2010; Grimaldi et al., 2011) . Estrogen and progesterone have been shown to down-regulate DNA methyltransferases (DNMTs) in vitro in endometrial explants (Vincent et al., 2011) . Two of our previous studies showed the role of the DNA methylation inhibition during decidualization by comparing 5-aza-2 ′ -deoxycytidine (AZA) to the treatment with dibutyryl-cAMP (db-cAMP)/estradiol/medroxy-progesterone acetate (MPA) in the human endometrial stromal cells (HESC) cell line (Logan et al., 2010; Logan et al., 2012) . We found that AZA can partially decidualize HESCs, possibly through the RhoGTPase family that reorganizes the cytoskeleton, and that p53 pathway members play a role in cell cycle regulation during decidualization. Subsequently, we found that AZA down-regulated the mRNA expression of all three DNMTs in HESCs, after 10 days of treatment (Supplementary data, Fig. S1 ). AZA has many molecular mechanisms that vary between cell types; but some of the mechanisms are not completely elucidated (Ghoshal et al., 2005; Schneider-Stock et al., 2005; Al-Salihi et al., 2011) . However, the main, known mechanism of action of AZA is incorporating into DNA, binding the DNMTs and inhibiting DNA methylation (Santi et al., 1984; Juttermann et al., 1994) . The three main DNMTs are DNMT1, the maintenance methyltransferase, and the de novo methyltransferases DNMT3A and DNMT3B, which each have gene-specific methylation sites in distinct genomic DNA regions (Hsieh, 1999; Okano et al., 1999; Takeshima et al., 2006) . The roles of the DNMTs are not entirely independent as DNMT3A and DNMT3B can substitute for DNMT1 and maintain the methylation of DNA (Liang et al., 2002; Walton et al., 2011) . Although aberrant DNA methylation of certain genes has been implicated in endometrial cancer and endometriosis (Wu et al., 2005; Wu et al., 2006; Xue et al., 2007) , the exact role of DNA methylation in gene regulation of the endometrium is still not well understood.
Although there is a consensus that the DNMTs are involved in decidualization (Yamagata et al., 2009; van Kaam et al., 2011; Vincent et al., 2011; Grimaldi et al., 2012; Zelenko et al., 2012) , there is also disagreement and even contradiction between these five studies on exactly when DNMT1, DNMT3A or DNMT3B are down-regulated, or even up-regulated, in the secretory phase (Guo, 2011) . Four of the studies determine gene expression of the DNMTs from tissue samples, which contain a mixture of various cell types, from the secretory versus proliferative phases (Yamagata et al., 2009; van Kaam et al., 2011; Vincent et al., 2011; Zelenko et al., 2012 The aim of the current study is to understand the role of DNA methylation and specifically the members of the DNMT family, DNMT1, DNMT3A and DNMT3B in modulating the effects of estrogen, progesterone and cAMP on the decidualization of human endometrial stromal cells in a HESC cell-line model.
Materials and Methods

Cell culture and treatment
The human endometrial stromal cells (HESC) cell line, immortalized with telomerase (human telomerase reverse transcriptase) (Krikun et al., 2004) . (Logan et al., 2010) . To prepare the HESC for experiments, 2 × 10 5 cells/well were plated in six-well plates.
The following day the HESC were primed with 10 nM 17b-estradiol (Sigma-Aldrich, St Louis, MO, USA) and treated the day after with MPA-mix (17b-estradiol, MPA, cAMP) in phenol red-free, 2% charcoalstripped, fetal bovine serum-supplemented DMEM/F12 medium (Invitrogen Life Technologies). The MPA-mix was formulated using the published concentrations for decidualizing endometrial stromal cells (Kessler et al. 2005; Tang et al., 1993a, b) . The concentrations used were 1 mM MPA (Calbiochem w , Sigma-Aldrich); 10 nM 17b-estradiol (Sigma-Aldrich); 0.3 mM db-cAMP) (Sigma-Aldrich) (Kasahara et al., 2001) . The treated HESCs in experiments were in low passage numbers of 16 -24.
An Olympus 1X71 camera and microscope system (TH4-200) were used to take images of the effect of the different treatments of MPA-mix, forced expression of DNMT3B, and empty vector control on the morphology and proliferation of HESC cells at 10 days.
Transient transfection of HESC
The plasmids were transfected into HESCs after 17b-estradiol priming for 24 h. For forced expression of DNMT3B, the pcDNA3/Myc-DNMT3B1 plasmid [pcDNA3 (Invitrogen), Addgene plasmid 35522] (Chen et al., 2005) containing the DNMT3B1 isoform (2562 bp) or the empty plasmid as vector control were transfected separately into 70% confluent HESCs in six-well plates using the transfection reagent FuGENE w HD (Roche Diagnostics, Auckland, New Zealand). Added to each well was 3 ml of FuGENE w HD and 0.75 mg of plasmid DNA, which had incubated for 15 min in 100 ml antibiotic-and serum-free media, according to the manufacturer's instructions.
Total cell count assay
The HESCs were plated at 40% confluency and treated for 10 days, collected by trypsinization, stained with trypan blue exclusion dye and counted using a hemocytometer under a bright field microscope. Trypan blue-stained dead cells were not counted. There were three independent experiments and in each experiment the treatments were in triplicate.
Total RNA extraction and quantitative real-time PCR Total RNA was extracted from HESCs using TRIZol w (Invitrogen Life Technologies) according to the manufacturer's instructions. Total RNA of 1 mg for each sample was DNase treated (Invitrogen Life Technologies) and converted to cDNA using the Transcriptor First Strand cDNA synthesis kit and random hexamers (Roche Diagnostics) according to the manufacturer's instructions. Semi-quantitative PCR was conducted to confirm the forced expression of DNMT3B, using Platinum w Blue PCR SuperMix (Invitrogen Life Technologies), run on a 2% agarose gel incorporating ethidium bromide and visualized in a transilluminator (UVP BioImaging Systems, Upland, CA, USA). The mRNA expression of the genes of interest (Table I) were measured by quantitative real-time PCR (qPCR) using SYBR Green 1 (Roche Diagnostics), according to the manufacturer's instructions, and performed in the LightCycler 480 Real-Time PCR System (Roche Diagnostics). The mean C t values of the triplicates for each treatment of each gene were normalized against the C t values of the reference gene 18S rRNA (RP18S1) in the DDC t method. The primer sequences and amplicon sizes are shown in Table I . PrimerBank IDs are as follows: AR, 349501065c3; PGR, 160358783c; prolactin, 4506105a2 (Wang and Seed, 2003) , 18S rRNA (Ponnampalam et al., 2004) , ERa (Latil et al., 2001) . qPCR quantified the transcript variants 1 and 2 of DNMT1, transcript variants 1, 2 and 3 of DNMT3A and transcript variants 1, 2, 3, 6, 7 and 8 of DNMT3B (www.ncbi.nlm.nih.gov/ tools/primer-blast/). The PRA expression cannot be measured directly because the two PR isoforms, PRA and PRB, are encoded on a single PGR gene, and the measurement of PRA mRNA expression includes PRB expression, whereas PRB mRNA expression can be separately measured from PGR expression.
Western blotting analysis
Total protein extracts from HESCs (20 mg) were diluted in 6× reducing Laemmli's sample buffer, which has been described before (Logan et al., 2012) , separated by 10% SDS-polyacrylamide gel electrophoresis and transferred onto a polyvinylidene fluoride membrane (Bio-Rad Laboratories, Hercules, CA, USA). Membranes were blocked with Tris-buffered saline (TBS) with Tween (3% fat-free milk in TBS containing 0.1% Tween 20), and incubated overnight at 48C with a mouse monoclonal DNMT3B antibody (ab13604, Abcam, Cambridge, UK). A secondary antibody of a conjugated peroxidase was used at 1:3000 dilution. Chemiluminescence detection by Super-Signal West Dura (Thermo Scientific, IL, USA) was performed according to the manufacturer's instructions, and the films were scanned by a densitometer (GS-800 Calibrated densitometer, Bio-Rad Laboratories). To detect the b-actin loading control, the membranes were reprobed with a mouse monoclonal anti-b-actin antibody (Santa Cruz Biotechnology).
Enzyme-linked immunosorbent assay
Three independent experiments were conducted for an enzyme-linked immunosorbent assay (ELISA) of IGFBP1 (#AB100539, Abcam, Cambridge, UK), which was performed according to the manufacturer's instructions. Conditioned media from each sample were collected from Days 8 -10 of treatment. All samples were assayed in duplicate and values were plotted against the standard curve. The result from each sample of conditioned media was normalized against the total RNA of the HESC cells (Aghajanova et al., 2010) .
Statistical analysis
Data were analyzed by one-way analysis of variance with Tukey's post test for pair-wise comparisons using GraphPad Prism version 5.03 for Windows, (GraphPad Software, San Diego, CA, USA, www.graphpad. com). All data are expressed as means and standard error of the mean (+SEM) and P , 0.05 was considered to be statistically significant.
Results
db-cAMP and estradiol/MPA treatments down-regulated DNMT1 and DNMT3B
We determined the effect of db-cAMP, estradiol/MPA and the combination MPA-mix on the gene expression of the DNMTs in HESCs in a time-course analysis during the period of decidualization. We chose the 6-, 24-, 48-h and 10-day time-points for the three treatments as the 6-h time-point is during the steroid hormone receptor activation in the early stage of decidualization; the 24-h time-point is prior to the cell division of HESCs; the 48-h time-point is in the intermediate stage of decidualization (Aghajanova et al., 2011) and the 10-day timepoint is when the decidualization markers of prolactin and IGFBP1 are up-regulated and the decidual cell morphology of HESCs becomes apparent (de Ziegler et al., 1998). Both the 48-h and 10-day time-points were used in our earlier studies of decidualization and the cell cycle (Logan et al., 2010; Logan et al., 2012) .
The mRNA expression of the three DNMTs was down-regulated at different times over 10 days (Fig. 1) . DNMT1 mRNA expression was significantly down-regulated by all three treatments of db-cAMP, estradiol/MPA and MPA-mix, after 48 h; in addition, it was down-regulated by db-cAMP after 24 h. DNMT3A was down-regulated following a 6-h treatment of db-cAMP and 48 h treatment of estradiol/MPA (Student's t-test P , 0.001). DNMT3B mRNA expression was consistently down-regulated throughout the treatment period, from 6 h to 10 day by all three treatments. The mean fold change of DNMT3B mRNA down-regulation over the time-course for all three treatments was 0.50 compared with control (SEM 0.096, n ¼ 3, P , 0.001) (Fig. 1) . The mean fold change of decreased DNMT3B protein level at 48 h from MPA-mix treatment was 0.51 compared with control (Supplementary data, Fig. S2 ).
MPA-mix treatment up-regulated steroid hormone receptors
We also examined the gene expression of the steroid hormone receptors that mediate the effects of estrogen, progesterone and cAMP during the period of decidualization induction: ERa, PGR, PRB and AR. Only the 24-and 48-h time-points are shown because they were the time-points with significant up-regulation of all the tested steroid hormone receptors. The combined MPA-mix treatment significantly induced the transcription of all four steroid hormone receptors after 24-and 48-h treatments (Fig. 2) . The individual treatments of db-cAMP and estradiol/MPA did not affect mRNA expression of the steroid hormone receptors at either time-point, except for the PGR expression which was up-regulated by db-cAMP treatment after 48 h.
HESC proliferation and morphology remained unaffected by DNMT3B forced expression
We decided to force express DNMT3B to determine whether DNMT3B would inhibit decidualization. Knock-down of the mRNA expression of all three DNMTs was induced previously by AZA (Logan et al., 2010; Logan et al., 2012) . Although the principle mechanism of AZA is to inhibit the methylation activity of the three DNMTs at the protein level, our data suggest that AZA also down-regulates the mRNA expression of all three DNMTs in HESCs at 10 days (Supplementary data, Fig. S1 ) (Schneider-Stock et al., 2005) . The inhibition by AZA of the protein and mRNA expression of all three DNMTs for at least 10 days was not sufficient to decidualize HESCs. However, other mechanisms of AZA could also have affected gene expression (Ghoshal et al., 2005) and inhibited decidualization, for example, the down-regulation of decorin (Logan et al., 2010) .
The transient forced expression of DNMT3B persisted for at least 10 days (Fig. 3) . The three MPA-mix treatments of MPA-mix, vector/ MPA and DNMT3B/MPA inhibited the proliferation of HESCs after 10 days compared with the control, vector and DNMT3B, in a total cell assay (Fig. 4A) . The inhibition of HESC proliferation correlates with the onset of decidualization and the transformation of HESC cellular morphology to a decidual-like morphology (Logan et al., 2012) . The two MPA-mix treatments, vector/MPA and DNMT3B/MPA, transformed the stromal cell morphology of HESCs into a decidual-like cell morphology after 10 days (Fig. 4B) . Figure 1 db-cAMP, estradiol/MPA and MPA-mix treatments down-regulated DNMT1, DNMT3A and DNMT3B mRNA expression during a time-course of 6 h to 10 days, determined by real-time qPCR [MPA-mix (1 mM MPA, 10 nM estradiol, 0.3 mM db-cAMP)]. The y-axis represents the fold change of mRNA levels following the three treatments compared with the control (mean + SEM, n ¼ 3, *P , 0.05, **P , 0.01, ***P , 0.001). db-cAMP, dibutyryl cyclic adenosine monophosphate; E2, estradiol; MPA, medroxy-progesterone acetate; DNMT, DNA methyltransferase. Figure 2 MPA-mix treatment up-regulated the steroid receptors ERa, PGR, PRB and AR mRNA expression at 24 h, determined by qPCR. The y-axis represents the fold change of mRNA levels following the three treatments of db-cAMP, estradiol/MPA and MPA-mix compared with the control (mean + SEM, n ¼ 3, *P , 0.05, **P , 0.01, ***P , 0.001). E2, estradiol; ERa, estrogen receptor alpha; PGR, total progesterone receptor A + B; PRB, progesterone receptor B; AR, androgen receptor.
DNMT3B forced expression attenuated IGFBP1 mRNA and protein expression after 10 days
Prolactin and IGFBP1 are the two established molecular markers for decidualization. Prolactin mRNA expression was significantly up-regulated by the two MPA-mix treatments in HESCs, vector/ MPA and DNMT3B/MPA, after 10 days (Fig. 4C) . IGFBP1 mRNA expression was also up-regulated by vector/MPA treatment as expected, however, the up-regulation was attenuated by the forced expression of DNMT3B in DNMT3B/MPA-treated cells (Fig. 4C) . Forced expression of DNMT3B alone significantly down-regulated IGFBP1 mRNA expression compared with the vector (Student's t-test P , 0.001).
An ELISA for IGFBP1 was performed with conditioned media after 10-day treatments of HESCs. The MPA-mix treatment of vector/MPA increased the IGFBP1 protein level compared with vector. However, forced expression of DNMT3B, in DNMT3B/MPA, attenuated the increase in IGFBP1 compared with vector/MPA treatment (Fig. 4D) .
The forced expression of DNMT3B increased the up-regulation of PRB mRNA expression
We treated HESCs forced expressed with DNMT3B with MPA-mix for 24 h because our time-course analysis results had shown that 24 h of treatment up-regulated all four ovarian steroid hormone receptors (Fig. 2) . Also at 24 h, there would have been less chance of a confounding interference from DNMT1 and DNMT3A because neither DNMT is down-regulated by MPA-mix treatment after 24 h; hence, only the effect of DNMT3B on the steroid hormone receptors might be identified. At 24 h, forced expression of DNMT3B and MPA-mix treatment, as with DNMT3B/MPA, synergistically increased PRB mRNA expression compared with MPA-mix treatment alone (Fig. 5) . The two MPA-mix treatments, vector/MPA and DNMT3B/ MPA, up-regulated PGR mRNA expression at 24 h. The increase of PRB up-regulation from forced expression of DNMT3B would have been incorporated into the PGR mRNA expression. Hence, the forced expression of DNMT3B possibly down-regulated PRA mRNA expression (determined by the subtraction of PRB from PGR). By 10 days the mRNA expression of PGR and PRB, from vector/MPA and DNMT3B/MPA treatments, returned to similar levels as those of vector control (Fig. 5) .
Discussion
This study aimed to understand the regulation of DNMTs by cAMP and estrogen/progesterone, and the role of DNMT3B in decidualization and its modulation of steroid hormone receptor expression in a previously established HESC decidualization model. The results show that both db-cAMP and estradiol/MPA treatments, independently and combined, down-regulated DNMT3B mRNA expression from as early as 6 h till 10 days of treatment; and down-regulated DNMT1 at 48 h. Interestingly, the forced expression of DNMT3B significantly attenuated mRNA and protein expression of the decidualization marker IGFBP1 after 10 days. Furthermore, DNMT3B and MPA-mix (DNMT3B/MPA) synergistically increased PRB mRNA expression, after 24 h, compared with the up-regulation of PRB by MPA-mix treatment alone.
Our results are in general agreement with most of the previous studies, which had shown that the mRNA expression of the three DNMTs are down-regulated at various times during decidualization (Yamagata et al., 2009; Vincent et al., 2011; Grimaldi et al., 2012; Zelenko et al., 2012) , except for the study by van Kaam et al. (2011) . Surprisingly, van Kaam et al. (2011) reported that DNMT1 was up-regulated in proliferative tissue explants treated with estradiol/progesterone at 24 h. This discrepancy in results could be attributed to the mixed cell types in the tissue explants and/or the The protein levels of DNMT3B forced expression at 24 h were determined by Western blotting. The y-axis represents the fold change of DNMT3B protein levels following the three treatments, DNMT3B, vector/MPA and DNMT3B/MPA compared with the vector control. b-actin was the loading control and results were normalized against it. The PCR gels and the Western blot were representative of three independent experiments (mean + SEM, n ¼ 3, *P , 0.05, ***P , 0.001). D3B, DNMT3B; D3B/M, DNMT3B/MPA-mix; DNMT3B, DNA methyltransferase 3B; V, vector; V/M, vector/MPA-mix. treatment time of 24 h compared with the other studies treating for at least 48 h. In addition, one of the main differences between the other studies (except Grimaldi et al.) and ours is the addition of cAMP in the treatment cocktail used to decidualize the stromal cells.
The importance of cAMP is often ignored in many in vitro studies. However, it is thought to be the initial activator of decidualization and to be crucial for the slow-acting progesterone pathway (Tang and Gurpide, 1993) . cAMP initiates decidualization with a sustained activation of the protein kinase A pathway that sensitizes the stromal cells to the activity of progesterone (Gellersen and Brosens, 2003) . The LH surge and the FSH peak stimulate cAMP at first (Tang and Gurpide, 1993) and then relaxin, corticotropin-releasing hormone, prostaglandin E2 or human chorionic gonadotropin from trophoblasts take over the stimulation of cAMP, until term if pregnancy occurs (Houserman et al., 1989; Tang et al., 1994; Telgmann and Gellersen, 1998; Makrigiannakis et al., 1999) . cAMP as the sole Figure 4 DNMT3B forced expression attenuated IGFBP1 mRNA expression and the increase of IGFBP1 protein at 10 days. (A) MPA-mix treatments of MPA-mix, vector/MPA and DNMT3B/MPA inhibited HESC proliferation at 10 days compared with the control, vector and DNMT3B. HESC were counted in a total cell count assay. The y-axis represents the mean cell number per field of a hemocytometer (mean + SEM, n ¼ 3, **P , 0.01, ***P , 0.001). (B) MPA-mix treatments of vector/MPA and DNMT3B/MPA transformed the HESC to have decidual-like morphologies. This experiment is representative of at least three independent experiments. Scale bar, 200mm (10× objective). (C) Effects of MPA-mix treatment of transfected DNMT3B and vector (vector/MPA and DNMT3B/MPA) on IGFBP1 and prolactin mRNA expression, at 10 days, as determined by qPCR. The y-axis represents the fold change of mRNA levels following the three treatments compared with the vector control (mean + SEM, n ¼ 3, **P , 0.01, ***P , 0.001). (D) IGFBP1 protein from the conditioned media from three independent experiments was detected by ELISA, and normalized against total RNA (mean + SEM, n ¼ 3, *P , 0.05). DNMT, DNA methyltransferase; IGFBP-1, insulin-like growth factor binding protein-1; HESC, human endometrial stromal cells; MPA, medroxy-progesterone acetate; ELISA, enzyme-linked immunosorbent assay. treatment has been shown to decidualize stromal cells (Pohnke et al., 2004; Cho et al., 2011) ; differentiate cells, such as trophoblasts (Yoshie et al., 2008) ; and suppress DNMTs during cell differentiation (Soultanas et al., 1993) . In vitro studies have confirmed that cAMP is fast, effective and decidualizes early, within 3 days; while progesterone is the slow, weak inducer of prolactin and decidualizes late, taking as long as 14 -23 days (Tang et al., 1993b; Gellersen and Brosens, 2003; Cloke et al., 2008) . The difference between the two pathways can be seen in this study at 48 h when cAMP up-regulated PGR mRNA expression and estradiol/MPA did not; and conversely, when estradiol/MPA down-regulated DNMT3A mRNA expression and cAMP did not. Further research is required to elucidate the molecular mechanisms.
In our time-course analysis, the combined treatments of cAMP and estradiol/MPA (as MPA-mix) up-regulated ERa, AR, PGR and PRB mRNA expression at 24 h compared with the separate treatments, which did not affect the expression of these steroid hormone receptors (Brosens et al., 1999; Cloke et al., 2010) . The levels of these ovarian steroid receptors vary during the menstrual cycle (Wang et al., 1998) . Estradiol priming up-regulates ERa, AR, PRA and PRB during the proliferative phase when expression of each reaches a peak and then the expression significantly decreases during the secretory phases due to progesterone (Garcia et al., 1988; Mertens et al., 2001) . Although cAMP and progesterone decrease the AR protein levels during decidualization, AR mRNA expression remains relatively unaffected (Cloke et al., 2010) .
The data from the present study show that the regulation of DNMT1 and DNMT3A mRNA expression was time-dependent during decidualization. The estradiol/MPA treatment downregulated DNMT3A at 48 h (Fig. 1) , which supports Yamagata et al. (2009) 's result of down-regulation of DNMT3A before 8 days, and confirms Vincent et al. (2011) and Grimaldi et al. (2012) 's result at 48 h. The possibility that DNMT1 might be up-regulated very early on as van Kaam et al. (2011) report for 24 h did not contradict our result at 6 h, although the mechanism that up-regulates DNMT1 has been elusive to find, especially in cancer (Zhang et al., 2012) . Indeed, in neural stem cells, DNMT1 increased to high levels at the onset of differentiation but subsequently both DNMT1 and DNMT3a were down-regulated as differentiation proceeded (Singh et al., 2009 ). Cellular differentiation is probably associated with both DNA methylation and demethylation (Shiota, 2004 ).
Figure 5
The forced expression of DNMT3B in MPA-mix-treated HESCs synergistically increased the up-regulation of PRB mRNA expression compared with MPA-mix alone, at 24 h, determined by qPCR. The y-axis represents the fold change of mRNA levels following the three treatments DNMT3B, vector/MPA and DNMT3B/MPA, compared with the vector control (mean + SEM, n ¼ 3, *P , 0.05, **P , 0.01, ***P , 0.001). HESC, human endometrial stromal cells; PRB, progesterone receptor B; PGR, total progesterone receptor A + B.
Interestingly, forced expression of DNMT3B attenuated the up-regulation of IGFBP1 mRNA and protein expression by MPA-mix (but did not affect prolactin). It is possible that DNMT3B hypermethylated the promoter of IGFBP1, which can occur in renal carcinoma (Ibanez de Caceres et al., 2006) . However, a study also showed that forced expression of PRB inhibited IGFBP1 mRNA and protein expression in endometrial cells (Gao and Tseng, 1997) . Our data showed that forced expression of DNMT3B synergistically increased PRB mRNA expression, at 24 h, when combined with MPA-mix compared with MPA-mix alone. The two PRs have separate, often opposing functions and regulate different genes (Mote et al., 2000; Tan et al., 2012) . PRA inhibits cell proliferation, while PRB stimulates it (Yudt et al., 2006) . PRA, the predominant PR in decidualization (Wang et al., 1998) , up-regulates IGFBP1 (Gao et al., 2000) and downregulates PRB (Vegeto et al., 1993) . From our results, the forced expression of DNMT3B had the opposite effect that PRA has on IGFBP1 and PRB.
Our finding that the forced expression of DNMT3B attenuated the up-regulation of IGFBP1 has implications for decidualization and endometriosis. IGFBP1 is a major secreted protein in decidualization and interacts with trophoblasts to slow invasion; and binds and regulates the insulin-like growth factors, IGF-I and IGF-II . Decreased IGFBP1 adversely affects trophoblast invasion and hence embryo implantation, and increases fetal growth Asvold et al., 2011) . In endometriosis, DNMT1, DNMT3A and DNMT3B are up-regulated , which hypermethylates and down-regulates HOXA10 (Wu et al., 2005) that consequently down-regulates IGFBP1 (Klemmt et al., 2006; Lee et al., 2009; Godbole and Modi, 2010) but not prolactin (Cunha-Filho et al., 2001; Minici et al., 2007) . However, Kim et al. (2007) disagree and contend that the down-regulation of HOXA10 up-regulates IGFBP1 in endometriosis.
The cell cycle can affect the expression of DNMT3B and DNMT1, which are low in the G0/G1 phases of the cell cycle (Robertson et al., 2000) but irrespective of the cell cycle phases DNMT3B expression in MPA-mix-treated HESCs was consistently low (Logan et al., 2012) .
In conclusion, this study shows that mRNA expression of the DNMTs during decidualization is dynamic, so that expression of DNMT1 and DNMT3A varies transiently in response to estrogen/ progesterone, cAMP or the combination of these two pathways in a time-dependent manner. However, DNMT3B was consistently downregulated by both pathways during decidualization. Although the forced expression of DNMT3B by itself is not sufficient to inhibit decidualization, it can up-regulate PRB mRNA expression and attenuate the expression of IGFBP1, the decidualization marker.
Supplementary data
Supplementary data are available at http://molehr.oxfordjournals. org/.
